Quantinuum (NASDAQ:QNT) Director Purchases $12,000.00 in Stock

Quantinuum Inc. (NASDAQ:QNTGet Free Report) Director Prineha Narang purchased 200 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, for a total transaction of $12,000.00. Following the transaction, the director owned 6,033 shares of the company’s stock, valued at approximately $361,980. This trade represents a 3.43% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Quantinuum Stock Performance

Shares of Quantinuum stock traded up $2.14 during midday trading on Monday, hitting $58.40. The company had a trading volume of 4,732,752 shares, compared to its average volume of 7,665,925. Quantinuum Inc. has a 1-year low of $51.15 and a 1-year high of $71.35.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Director Hal Barron bought 250,000 shares for $15.0 million, one of the largest insider purchases in the group, signaling strong confidence in Quantinuum’s outlook. SEC filing
  • Positive Sentiment: Director Joseph Jimenez acquired 66,665 shares, while Director Manish H. Bhatia, Kenneth D. Denman, Paul R. Daugherty, Eric Branderiz, Vimal Kapur, and others also added to their stakes, reinforcing the bullish insider-buying trend. SEC filing
  • Neutral Sentiment: The shares were bought at $60 each, which is near the recent trading range and may be viewed as a meaningful reference point for investors assessing valuation. Stock page
  • Neutral Sentiment: A recent Seeking Alpha article, “Quantinuum: Buying Apollo Today,” adds to market attention around the stock, but the main near-term driver appears to be insider activity rather than a new operational update. Article

See Also

Insider Buying and Selling by Quarter for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.